Mankind Pharma and Innovent Biologics Partner to Launch Groundbreaking PD-1 Immunotherapy in India

Duchenne Muscular Dystrophy: Diagnosis, Treatment, and Emerging Therapies

Ikena Oncology and Inmagene Biopharmaceuticals Announce Merger to Form ImageneBio

Fujirebio and Eisai Partner to Advance Diagnostics for Neurodegenerative Diseases

European Commission Approves Opdivo® Plus Yervoy® for First-Line Treatment of MSI-H or dMMR mCRC

Deerfield Management to Acquire Singular Genomics for $20 Per Share in All-Cash Deal

EU Approval of Tagrisso Sets New Standard for EGFR-Mutated NSCLC Treatment

Aurobindo Pharma’s Subsidiary CuraTeQ Secures UK Approval for Bevacizumab Biosimilar

SCG Cell Therapy Partners with A*STAR BTI and NATi to Advance RNA-Based Therapeutics

Korea's National Bio Big Data Project: Advancing Precision Medicine with Macrogen and Illumina

GST Exemption Announced for Cancer Treatment Gene Therapy

AIIMS Develops Affordable CAR-T Cell Therapy for Multiple Myeloma

Sangamo Therapeutics and Astellas Collaborate on Innovative Gene Therapy for Neurological Diseases

FDA Clears IND for Arbor Biotechnologies’ ABO-101 Gene Editing Therapeutic for Primary Hyperoxaluria Type 1

Fortis Healthcare Acquires Stake in Agilus Diagnostics

Home
/
update
/
details

Aster DM Healthcare Revolutionizes Cancer Care with Precision Oncology Initiatives

NextEdge Admin

15 Dec 2024

2 min 41 sec

Precision Oncology Clinics,cancer treatment,research,data management

Aster DM Healthcare, one of India’s largest integrated healthcare providers, unveiled three transformative initiatives—Precision Oncology Clinics, the Aster Cancer Grid, and Onco Collect—during the Aster Cancer Conclave 2024. These advancements represent a significant leap in cancer treatment and research in India.

The Conclave, themed PRISM: Precision in Solid Malignancies, brought together leading oncologists, researchers, and industry experts to discuss cutting-edge developments in cancer care. The focus was on the growing importance of precision medicine in revolutionizing treatment for solid tumors.

The Precision Oncology Clinics aim to personalize cancer treatment based on a patient’s genomic profile, marking a departure from traditional, one-size-fits-all approaches. This tailored therapy approach leverages tumor-specific genomic data to customize treatment, improving effectiveness and reducing adverse effects, thereby offering more efficient and patient-centric care.

The Aster Cancer Grid is set to drive collaborative research, facilitate multi-center clinical trials, and standardize cancer care across Aster Hospitals. By aggregating data and fostering partnerships with pharmaceutical companies, biotech firms, and research institutions, the Grid seeks to advance cancer research and innovation. Its collaboration with international research centers will promote global knowledge sharing, best practices, and opportunities for joint funding, grants, and research initiatives.

The Onco Collect platform, developed by the Dr. Ramesh Nimmegadda Cancer Foundation, was launched across Aster Hospitals in Bengaluru. This cutting-edge software streamlines oncology data management by consolidating patient information into a single, standardized database. It enables outcome analysis and supports evidence-based treatment planning, ensuring consistent, high-quality cancer care.

Together, these initiatives exemplify Aster DM Healthcare’s commitment to leveraging precision medicine and innovative technologies to elevate cancer care in India to global standards.